Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy

• Status: Completed
• Trial end date: 2008-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The study hypothesis: Valsartan as an angiotensin II receptor blocker treatment has beneficial effects on both midwall mechanics and myocardial functions in hypertensive patients with Left ventricular hypertrophy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mustafa Kemal University
• Collaborator: Novartis Pharmaceuticals
• Treatments: Valsartan

Criteria

Inclusion Criteria:

• hypertension with left ventricular hypertrophy

Exclusion Criteria:

• clinical or laboratory evidence of secondary hypertension

• heart failure

• ischemic heart disease

• valvular heart disease

• arrhythmias

• peripheral vascular disease

• chronic obstructive pulmonary disease

• neurologic disorders

• diabetes mellitus

• renal dysfunction

• notable systemic disease